Inventor · disambiguated record
Sung-Hyung Lee
Also filed as: LEE SUNG-HYUNG
18 granted patents·9 pending applications·197 citations·filing 2015–2025
94Inventor score
Files withXENCOR INC27
Top patents by PatentIndex Score
27 records- 0198US10428155B2Trispecific antibodiesXENCOR INC·Filed 2015·Granted Oct 1, 2019·39 cites·5 claims
- 0298US10259887B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2016·Granted Apr 16, 2019·25 cites·25 claims
- 0398US9856327B2Heterodimeric antibodies to CD3 X CD123XENCOR INC·Filed 2016·Granted Jan 2, 2018·72 cites·5 claims
- 0497US11472890B2Heterodimeric antibodies that bind ENPP3 and CD3XENCOR INC·Filed 2020·Granted Oct 18, 2022·9 cites·4 claims
- 0597US11225528B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2019·Granted Jan 18, 2022·11 cites·13 claims
- 0695US11225521B2Heterodimeric antibodies that bind somatostatin receptor 2XENCOR INC·Filed 2019·Granted Jan 18, 2022·11 cites·23 claims
- 0795US9850320B2Heterodimeric antibodies to CD3 X CD20XENCOR INC·Filed 2016·Granted Dec 26, 2017·13 cites·5 claims
- 0892US12398207B2Heterodimeric antibodies that bind CD3 and CLDN6XENCOR INC·Filed 2024·Granted Aug 26, 2025·1 cites·4 claims
- 0992US11945880B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2021·Granted Apr 2, 2024·1 cites·13 claims
- 1092US11859011B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2021·Granted Jan 2, 2024·1 cites·2 claims
- 1192US10316088B2Heterodimeric antibodies that bind somatostatin receptor 2XENCOR INC·Filed 2017·Granted Jun 11, 2019·11 cites·4 claims
- 1288US12359002B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2023·Granted Jul 15, 2025·0 cites·2 claims
- 1388US2025109215A1Heterodimeric antibodies that bind cd3 and tumor antigensXENCOR INC·Filed 2024·Application pending·0 cites
- 1488US2025304724A1Heterodimeric antibodies that bind cd3 and tumor antigensXENCOR INC·Filed 2025·Application pending·0 cites
- 1586US10889653B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2015·Granted Jan 12, 2021·2 cites·4 claims
- 1684US10913803B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2018·Granted Feb 9, 2021·1 cites·11 claims
- 1778US11673972B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2020·Granted Jun 13, 2023·0 cites·7 claims
- 1877US12054545B2Heterodimeric antibodies that bind somatostatin receptor 2XENCOR INC·Filed 2021·Granted Aug 6, 2024·0 cites·6 claims
- 1977US2024228608A9Heterodimeric antibodies that bind cd3 and cldn6XENCOR INC·Filed 2023·Application pending·0 cites
- 2076US11739144B2Heterodimeric antibodies that bind CD3 and CLDN6XENCOR INC·Filed 2022·Granted Aug 29, 2023·0 cites·5 claims
- 2175US2023086017A1Trispecific antibodiesXENCOR INC·Filed 2022·Application pending·0 cites
- 2270US11111315B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2018·Granted Sep 7, 2021·0 cites·11 claims
- 2369US2023227581A1Heterodimeric antibodies that bind enpp3 and cd3XENCOR INC·Filed 2022·Application pending·0 cites
- 2466US2024166705A1Il18-fc fusion proteinsXENCOR INC·Filed 2023·Application pending·0 cites
- 2565US2019352416A1Trispecific antibodiesXENCOR INC·Filed 2019·Application pending·0 cites
- 2661US2023146665A1Il-18-fc fusion proteinsXENCOR INC·Filed 2022·Application pending·0 cites
- 2739US2016176969A1Heterodimeric antibodies including binding to cd8XENCOR INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sung-Hyung Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →